The short version
16 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Cyclobenzaprine Hydrochloride
Cyclobenzaprine Hydrochloride · CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 · Capsule, Extended Release · Oral · Preferred Pharmaceuticals Inc.
NDC 68788-4087-03 · 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 24979-0035-04) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$2.06per unit
middle half $1.97–$2.06 · 8 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $2.06
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
0%of plans cover it
tier 4 · prior auth 100% · step therapy 0% · qty limit 0%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for cyclobenzaprine hydrochloride (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Preferred Pharmaceuticals Inc.United Statesrepack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA021777
- TE code
- AB
- Approval date
- Feb 1, 2007
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Cyclobenzaprine Hydrochloride (Capsule, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Remedyrepack Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Adare Pharmaceuticals, Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Adare Pharmaceuticals, Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals of New York LLC | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals of New York LLC | CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Asclemed USA, Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Asclemed USA, Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cephalon, LLC | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cephalon, LLC | CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Direct Rx | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Doc Rx | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals, Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Upsher-Smith Laboratories, LLC | CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Upsher-Smith Laboratories, LLC | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advanced Rx of Tennessee, LLC | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Proficient Rx LP | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Phoenix Rx Llc | CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
| Remedyrepack Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Cyclobenzaprine Hydrochloride — NDC 68788-4087-03," retrieved September 3, 2026, https://drugdashboards.com/drug/68788408703.
Free to cite with attribution — see how the data is put together.